Paradigm Biopharmaceuticals’ flagship drug Zilosul will be in Phase 3 in 2025
Paradigm Biopharmaceuticals (ASX:PAR) has been listed for nearly a decade with the goal of bringing its flagship drug pentosan polysulfate…
Read More
Findi (ASX:FND): It’s quadrupled in 12 months off the back of financial services in India
Until Findi (ASX:FND) came along, there were practically no ASX companies making money from India (or at least not many…
Read More
Here are 5 key ASX Listing Rules that investors need to know about!
All companies listed on the ASX need to know about the ASX Listing Rules. The reason is obvious: Because there’s…
Read More